cilastatin has been researched along with Primary Peritonitis in 38 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (10.53) | 18.7374 |
1990's | 27 (71.05) | 18.2507 |
2000's | 4 (10.53) | 29.6817 |
2010's | 3 (7.89) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bi, J; Chen, X; Chen, Z; Cooper, A; Leng, X; Li, R; Liu, D; Ma, X; Maroko, R; Quan, Z; Wei, J; Wu, J; Wu, Z; Yan, L; Yu, Y; Zhang, Y | 1 |
Higashi, M; Iwasaka, T; Kakimoto, S; Kido, E; Morimoto, S; Morita, T; Someya, K; Sumitani, N; Suzuki, K; Takagishi, H; Yasui, A | 1 |
Couet, W; Grégoire, N; Marliat, M; Mimoz, O; Nordmann, P; Poirel, L | 1 |
Kotapati, S; Kuti, JL; Nicolau, DP | 1 |
Babinchak, T; Campos, M; Ellis-Grosse, EJ; Loh, E; Oliva, ME; Pasternak, J; Rekha, A; Rose, GM; Yellin, A | 1 |
Bonello, M; Dell'Aquila, R; Loreto, PD; Nalesso, F; Rodighiero, MP; Ronco, C; Spanò, E | 1 |
Giercksky, KE; Lundblad, R | 1 |
De Vecchi, AF | 1 |
Cheng, AB; Lai, KN; Leung, CB; Li, PK; Lui, SF; Wong, KC | 1 |
Akli, J; Fichaux, A | 1 |
Levy, E; Levy, P | 1 |
Carles, J; Janvier, G | 1 |
Chloroyiannis, J; Giamarellou, H; Kanellakopoulou, K; Papadothomakos, P; Sfikakis, P; Theakou, R; Tsipras, H | 1 |
Colardyn, F; Faulkner, KL | 1 |
Bohnen, J; Christou, NV; Potvin, M; Rotstein, O; Turgeon, P; Wassef, R | 1 |
Barie, PS; Baumgartner, TF; Dellinger, EP; Rotstein, OD; Solomkin, JS; Vogel, SB; Yang, JY | 1 |
Garnache, F; Goffinet, P; Simon, M | 1 |
Faulkner, K; Wilson, SE | 1 |
Campise, M | 1 |
Ambrosetti, P; Aymon, D; Bille, J; Chiolero, R; Cometta, A; Glauser, MP; Harbarth, S; Huber, O; Jaccard, C; Lew, D; Praz, G; Ricou, B; Romand, J; Schneider, R; Troillet, N; Zanetti, G | 1 |
Gaus, W; Kujath, P; Lünstedt, B; Rodloff, AC | 1 |
Crespo, M; Marcén, R; Ortuño, J; Rivera, M; Teruel, JL | 1 |
Chautemps, R; Ganeo, M; Glauser, M; Harbarth, SJ; Lange, J; Lew, D; Morel, P; Mosimann, F; Trampuz, A; Zanetti, G; Zimmerli, W | 1 |
Hogaboam, CM; Kunkel, SL; Lukacs, NW; Steinhauser, ML; Strieter, RM | 1 |
Bleichrodt, RP; Kooi, K; Rosman, C; Westerveld, GJ | 1 |
Briskin, BS; Khachatrian, NN; Kuznetsov, EV; Nekrasova, NI; Sosnovikova, OG; Suplotova, AA | 1 |
Atkinson, AM; Teale, DM | 1 |
Claesson, G; Eriksson, M; Rogers, JD | 1 |
Cruz, C; del Busto, R; Faber, MD; Mezger, E | 1 |
Fuchimoto, S; Hamada, F; Kimura, H; Kitagawa, T; Konaga, E; Nishiyama, Y; Ogawa, K; Orita, K; Takeuchi, H; Tokuda, N | 1 |
Canteras, M; Gómez, J; Martín-Luengo, F; Ros, J; Ruiz, J; Valdés, M | 1 |
Busuttil, RW; Christou, NV; Dellinger, EP; Solomkin, JS | 1 |
Cevallos, R; Denis, F; Mounier, M; Pezé, P | 1 |
Johnson, E; Kennedy, RH; Leaper, DJ; Roberts, N; Sutton, A | 1 |
Avery, D; Kennedy, R; Leaper, D; Leow, C; Thomas, W | 1 |
Iida, S; Kohara, T; Matsui, Y; Noda, M; Ooiwa, K | 1 |
Aebert, H; Bunzendahl, H; Hünefeld, G; Weissbrodt, H | 1 |
18 trial(s) available for cilastatin and Primary Peritonitis
Article | Year |
---|---|
Efficacy and safety of tigecycline monotherapy vs. imipenem/cilastatin in Chinese patients with complicated intra-abdominal infections: a randomized controlled trial.
Topics: Adult; Aged; Anti-Bacterial Agents; Asian People; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Female; Humans; Imipenem; Male; Middle Aged; Minocycline; Peritonitis; Tigecycline; Treatment Outcome | 2010 |
A multicenter trial of the efficacy and safety of tigecycline versus imipenem/cilastatin in patients with complicated intra-abdominal infections [Study ID Numbers: 3074A1-301-WW; ClinicalTrials.gov Identifier: NCT00081744].
Topics: Abdomen; Adult; Anti-Bacterial Agents; Appendicitis; Bacterial Infections; Cholecystitis; Cilastatin; Cilastatin, Imipenem Drug Combination; Diverticulitis; Double-Blind Method; Drug Combinations; Female; Humans; Imipenem; Intestinal Perforation; Male; Middle Aged; Minocycline; Peptic Ulcer Perforation; Peritonitis; Tigecycline | 2005 |
Imipenem/cilastatin sodium in the treatment of continuous ambulatory peritoneal dialysis-associated peritonitis.
Topics: Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Humans; Imipenem; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Staphylococcal Infections; Time Factors | 1994 |
[Contribution of imipenem/cilastatin in the treatment of peritonitis: a comparative economic analysis in the case of France].
Topics: Anti-Bacterial Agents; Cilastatin; Drug Therapy, Combination; Female; France; Humans; Imipenem; Length of Stay; Male; Middle Aged; Peritonitis; Prospective Studies; Retrospective Studies | 1993 |
[Efficacy and tolerance of imipenem/cilastatin in the adjuvant treatment of surgery for peritonitis in patients over the age of 70 years].
Topics: Aged; Aged, 80 and over; Cilastatin; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Peritonitis; Prospective Studies | 1993 |
Meropenem versus imipenem/cilastatin in the treatment of intraabdominal infections requiring surgery.
Topics: Adult; Aged; Cilastatin; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Humans; Imipenem; Male; Meropenem; Middle Aged; Peritonitis; Prospective Studies; Thienamycins; Treatment Outcome | 1993 |
Intravenous meropenem versus imipenem/cilastatin in the treatment of serious bacterial infections in hospitalized patients. Meropenem Serious Infection Study Group.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Cilastatin; Drug Therapy, Combination; Female; Hospitals; Humans; Imipenem; Infusions, Intravenous; Injections, Intravenous; Male; Meropenem; Middle Aged; Peritonitis; Protease Inhibitors; Respiratory Tract Infections; Thienamycins; Time Factors; Treatment Outcome; Urinary Tract Infections | 1996 |
Management of intra-abdominal infections. The case for intraoperative cultures and comprehensive broad-spectrum antibiotic coverage. The Canadian Intra-abdominal Infection Study Group.
Topics: Abdomen; Antibiotic Prophylaxis; Bacteria; Bacterial Infections; Cause of Death; Cefoxitin; Cephamycins; Cilastatin; Double-Blind Method; Drainage; Drug Resistance, Microbial; Female; Humans; Imipenem; Injections, Intravenous; Intraoperative Care; Male; Middle Aged; Peritonitis; Prospective Studies; Protease Inhibitors; Thienamycins; Treatment Failure; Treatment Outcome | 1996 |
[Peritonitis: dual treatment strategy of operation and antibiotics].
Topics: Adult; Cilastatin; Cilastatin, Imipenem Drug Combination; Combined Modality Therapy; Cost-Benefit Analysis; Debridement; Drug Combinations; Drug Therapy, Combination; Humans; Imipenem; Microbial Sensitivity Tests; Peritonitis; Survival Rate; Treatment Outcome | 1997 |
A randomized, double-blind clinical trial comparing cefepime plus metronidazole with imipenem-cilastatin in the treatment of complicated intra-abdominal infections. Cefepime Intra-abdominal Infection Study Group.
Topics: Abdomen; Abdominal Abscess; Adult; Aged; Antitrichomonal Agents; Appendicitis; Cefepime; Cephalosporins; Cilastatin; Double-Blind Method; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Humans; Imipenem; Infections; Male; Metronidazole; Middle Aged; Peritonitis; Treatment Outcome | 1997 |
Impact an anatomical site on bacteriological and clinical outcome in the management of intra-abdominal infections.
Topics: Adult; Aged; Anti-Bacterial Agents; Appendicitis; Bacterial Infections; Bacteriological Techniques; Cause of Death; Cilastatin; Clindamycin; Combined Modality Therapy; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Humans; Imipenem; Male; Meropenem; Middle Aged; Peritonitis; Risk Factors; Survival Rate; Thienamycins; Tobramycin; Treatment Outcome | 1998 |
Prospective randomized comparison of imipenem-cilastatin and piperacillin-tazobactam in nosocomial pneumonia or peritonitis.
Topics: Acute Disease; Adult; Aged; Cilastatin; Cilastatin, Imipenem Drug Combination; Cross Infection; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Pneumonia; Prospective Studies; Pseudomonas Infections; Tazobactam | 1998 |
[Comparative study of the cost-effectiveness of initial therapy with imipenem/cilastatin in secondary peritonitis].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cilastatin; Cost-Benefit Analysis; Drug Costs; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged; Peritonitis; Prospective Studies; Surgical Wound Infection | 1998 |
Meropenem (1.5 g/day) is as effective as imipenem/cilastatin (2 g/day) for the treatment of moderately severe intra-abdominal infections.
Topics: Adult; APACHE; Cilastatin; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Meropenem; Middle Aged; Peritonitis; Thienamycins | 1999 |
[Clinical evaluation of intramuscular imipenem/cilastatin sodium in surgical infections].
Topics: Adult; Aged; Cholangitis; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Female; Humans; Imipenem; Injections, Intramuscular; Male; Microbial Sensitivity Tests; Middle Aged; Peritonitis; Postoperative Complications | 1991 |
Results of a multicenter trial comparing imipenem/cilastatin to tobramycin/clindamycin for intra-abdominal infections.
Topics: Abscess; Adult; Aged; Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Clindamycin; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged; Peritonitis; Prospective Studies; Severity of Illness Index; Tobramycin | 1990 |
Treatment of acute bacterial peritonitis: a trial of imipenem/cilastatin against ampicillin-metronidazole-gentamicin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Clinical Trials as Topic; Cyclopropanes; Drug Combinations; Drug Therapy, Combination; Female; Gentamicins; Humans; Imipenem; Male; Metronidazole; Middle Aged; Peritonitis; Random Allocation; Thienamycins | 1987 |
Treatment of intra-abdominal infections using imipenem/cilastatin.
Topics: Aged; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Clinical Trials as Topic; Drug Combinations; Female; Gentamicins; Humans; Imipenem; Male; Metronidazole; Peritonitis | 1987 |
20 other study(ies) available for cilastatin and Primary Peritonitis
Article | Year |
---|---|
Peritonitis after gynecological and gastroscopic examinations in a peritoneal dialysis patient.
Topics: Amikacin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Enterococcus; Female; Gastroscopy; Gynecological Examination; Humans; Imipenem; Middle Aged; Peritoneal Dialysis; Peritonitis; Secondary Prevention; Treatment Outcome; Vancomycin | 2010 |
Broad-spectrum β-lactam antibiotics for treating experimental peritonitis in mice due to Klebsiella pneumoniae producing the carbapenemase OXA-48.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cefotaxime; Ceftazidime; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Ertapenem; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Lethal Dose 50; Mice; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Plasmids; Survival Rate | 2012 |
Pharmacodynamic modeling of beta-lactam antibiotics for the empiric treatment of secondary peritonitis: a report from the OPTAMA program.
Topics: Anti-Bacterial Agents; beta-Lactams; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Models, Biological; Monte Carlo Method; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins | 2005 |
Successful use of sodium hypochlorite pack plus systemic and local antibiotic therapy for the treatment of pseudomonas infection of peritoneal dialysis catheter exit-site.
Topics: Anti-Bacterial Agents; Catheters, Indwelling; Cilastatin; Cross Infection; Disinfectants; Drug Therapy, Combination; Humans; Imipenem; Infection Control; Kidney Failure, Chronic; Peritoneal Dialysis; Peritonitis; Pseudomonas Infections; Sodium Hypochlorite | 2007 |
Effect of volume support, antibiotic therapy, and monoclonal antiendotoxin antibodies on mortality rate and blood concentrations of endothelin and other mediators in fulminant intra-abdominal sepsis in rats.
Topics: Animals; Antibodies, Monoclonal; Blood Volume; Cilastatin; Cilastatin, Imipenem Drug Combination; Combined Modality Therapy; Drug Combinations; Drug Evaluation, Preclinical; Drug Therapy, Combination; Endothelins; Fluid Therapy; Imipenem; Immunoglobulins; Male; Peritonitis; Prospective Studies; Random Allocation; Rats; Rats, Wistar; Sepsis; Time Factors | 1995 |
Imipenem/cilastatin in the treatment of CAPD peritonitis.
Topics: Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Humans; Imipenem; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 1995 |
[Contribution of imipenem-cilastatin in the treatment of peritonitis: a comparative economical analysis in the case of France].
Topics: Cilastatin; Drug Therapy, Combination; France; Humans; Imipenem; Peritonitis | 1993 |
[Primary peritonitis caused by Streptococcus pneumoniae].
Topics: Abdominal Pain; Adult; Amikacin; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteremia; Cilastatin; Diarrhea; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Laparotomy; Penicillins; Peritonitis; Pneumococcal Infections; Protease Inhibitors; Puerperal Infection; Thienamycins; Treatment Outcome; Vagina | 1997 |
Neurological complication during imipenem/cilastatin therapy in uraemic patients.
Topics: Aged; Aged, 80 and over; Cilastatin; Confusion; Female; Humans; Imipenem; Male; Middle Aged; Nervous System; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Protease Inhibitors; Seizures; Thienamycins; Tremor; Uremia | 1998 |
Neurotoxicity due to imipenem/cilastatin in patients on continuous ambulatory peritoneal dialysis.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Humans; Imipenem; Kidney Failure, Chronic; Male; Middle Aged; Myoclonus; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Protease Inhibitors; Pruritus; Thienamycins | 1999 |
Multiple roles for IL-12 in a model of acute septic peritonitis.
Topics: Acute Disease; Animals; Cecal Diseases; Cilastatin; Cilastatin, Imipenem Drug Combination; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Female; Fibrosis; Imipenem; Immune Sera; Immunization, Passive; Interferon-gamma; Interleukin-10; Interleukin-12; Intestinal Perforation; Ligation; Mice; Peritoneum; Peritonitis; Sepsis; Wound Healing | 1999 |
Local treatment of generalised peritonitis in rats; effects on bacteria, endotoxin and mortality.
Topics: Abdominal Abscess; Animals; Anti-Infective Agents, Local; Cilastatin; Debridement; Drug Combinations; Endotoxins; Imipenem; Instillation, Drug; Male; Peritonitis; Protease Inhibitors; Rats; Rats, Wistar; Taurine; Therapeutic Irrigation; Thiadiazines; Thienamycins | 1999 |
[Experience in the use of imipenem/cilastatin (thienam) in a surgical clinic].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Cilastatin; Cilastatin, Imipenem Drug Combination; Diabetic Foot; Drug Combinations; Female; Humans; Imipenem; Male; Middle Aged; Pancreatitis, Acute Necrotizing; Peritonitis; Postoperative Care; Protease Inhibitors; Suppuration; Thienamycins | 2000 |
Inhibition of nitric oxide synthesis improves survival in a murine peritonitis model of sepsis that is not cured by antibiotics alone.
Topics: Amino Acid Oxidoreductases; Animals; Arginine; Cilastatin; Cilastatin, Imipenem Drug Combination; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Escherichia coli Infections; Imipenem; Male; Mice; Nitric Oxide Synthase; omega-N-Methylarginine; Peritonitis | 1992 |
Pharmacokinetics of imipenem/cilastatin sodium in children with peritonitis.
Topics: Child; Child, Preschool; Cilastatin; Drug Therapy, Combination; Humans; Imipenem; Infusions, Intravenous; Peritonitis | 1992 |
Response of Weeksella virosa peritonitis to imipenem/cilastin.
Topics: Adult; Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Female; Gram-Negative Bacterial Infections; Humans; Imipenem; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 1991 |
Comparison of the efficacy of three different treatments with imipenem versus the classical clindamycin plus tobramycin in experimental peritonitis.
Topics: Abscess; Animals; Ascitic Fluid; Cilastatin; Clindamycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Imipenem; Peritonitis; Rats; Rats, Inbred Strains; Tobramycin | 1991 |
[Study of the intraperitoneal penetration of imipenem/cilastatin in acute peritonitis with perforation].
Topics: Acute Disease; Aged; Cilastatin; Drug Therapy, Combination; Female; Humans; Imipenem; Intestinal Perforation; Male; Peritoneal Cavity; Peritonitis | 1990 |
[Experience with imipenem/cilastatin sodium in the field of obstetrics and gynecology].
Topics: Abscess; Adult; Cilastatin; Cyclopropanes; Drug Combinations; Female; Genitalia, Female; Humans; Imipenem; Middle Aged; Pelvis; Peritonitis; Salpingitis; Thienamycins; Vulvar Diseases | 1986 |
[Calculated initial chemotherapy in mechanically-ventilated postoperative patients with peritonitis, sepsis and pneumonia].
Topics: Adult; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Cyclopropanes; Drug Combinations; Female; Humans; Imipenem; Male; Middle Aged; Peritonitis; Pneumonia; Postoperative Complications; Respiration, Artificial; Retrospective Studies; Sepsis; Thienamycins | 1986 |